Results 331 to 340 of about 159,964 (350)

Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial.

The Lancet Oncology, 2020
V. Subbiah, U. Lassen, E. Élez, A. Italiano, G. Curigliano, M. Javle, F. de Braud, G. Prager, R. Greil, A. Stein, A. Fasolo, J. Schellens, P. Wen, K. Viele, A. Boran, E. Gasal, P. Burgess, P. Ilankumaran, Z. Wainberg   +18 more
semanticscholar   +1 more source

Global cancer statistics, 2012

Ca-A Cancer Journal for Clinicians, 2015
Frank Bray, Rebecca L Siegel, Joannie Lortet-Tieulent   +2 more
exaly  

Global cancer statistics

Ca-A Cancer Journal for Clinicians, 2011
Frank Bray
exaly  

Colorectal cancer statistics, 2020

Ca-A Cancer Journal for Clinicians, 2020
Rebecca L Siegel, Kimberly D Miller, Stacey A Fedewa   +2 more
exaly  

Cancer statistics, 2018

Ca-A Cancer Journal for Clinicians, 2018
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal Dvm   +2 more
exaly  

Cancer statistics in China, 2015

Ca-A Cancer Journal for Clinicians, 2016
Rongshou Zheng, Peter D Baade, Siwei Zhang   +2 more
exaly  

Cancer statistics, 2016

Ca-A Cancer Journal for Clinicians, 2016
Rebecca L Siegel, Kimberly D Miller
exaly  

Cancer statistics, 2017

Ca-A Cancer Journal for Clinicians, 2017
Rebecca L Siegel, Kimberly D Miller
exaly  

Cancer statistics, 2015

Ca-A Cancer Journal for Clinicians, 2015
Rebecca L Siegel
exaly  

Cancer statistics, 2013

Ca-A Cancer Journal for Clinicians, 2013
Ahmedin Jemal
exaly